Press Releases Year None202320222021 March 1, 2023 NewAmsterdam Pharma to Present at Cowen 43rd Annual Health Care Conference February 9, 2023 NewAmsterdam Pharma to Present at the SVB Securities Global BioPharma Conference February 6, 2023 NewAmsterdam Pharma Appoints John W. Smither to its Board of Directors January 17, 2023 NewAmsterdam Announces Positive Results from ROSE2, Phase 2 Trial Evaluating Obicetrapib in Combination with Ezetimibe as an Adjunct to High-Intensity Statin Therapy
January 17, 2023 NewAmsterdam Announces Positive Results from ROSE2, Phase 2 Trial Evaluating Obicetrapib in Combination with Ezetimibe as an Adjunct to High-Intensity Statin Therapy
